{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:20:35Z","timestamp":1786119635291,"version":"build-2736575974"},"reference-count":57,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/bor.0b013e328341152f","type":"journal-article","created":{"date-parts":[[2010,10,29]],"date-time":"2010-10-29T05:06:52Z","timestamp":1288328812000},"page":"50-56","source":"Crossref","is-referenced-by-count":66,"title":["Pyoderma gangraenosum"],"prefix":"10.1097","volume":"23","author":[{"given":"Uwe","family":"Wollina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Haroske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1750-1172-2-19","article-title":"Pyoderma gangraenosum: a review","volume":"2","author":"Wollina","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jaad.2008.11.017","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene","volume":"61","author":"Hong","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R3-10-20210128","first-page":"413","article-title":"The inherited autoinflammatory syndrome: a decade of discovery","volume":"120","author":"Goldfinger","year":"2009","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-065X.2008.00747.x","article-title":"PEST family phosphatases in immunity, autoimmunity, and autoinflammatory disorders","volume":"228","author":"Veillette","year":"2009","journal-title":"Immunol Rev"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"e6147","DOI":"10.1371\/journal.pone.0006147","article-title":"Pyrin modulates the intracellular distribution of PSTPIP1","volume":"4","author":"Waite","year":"2009","journal-title":"PLoS One"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.jaad.2009.02.033","article-title":"Disseminated pyoderma gangrenosum: role for vascular endothelial growth factor and hypoxia inducible factor-2","volume":"61","author":"Chua","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/11310730-000000000-00000","article-title":"Neutrophilic dermatoses: a review of current treatment options","volume":"10","author":"Cohen","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/j.1468-3083.2009.03199.x","article-title":"Pyoderma gangrenosum: an updated review","volume":"23","author":"Ruocco","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R10-10-20210128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/MD.0b013e318187cc9c","article-title":"Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients","volume":"87","author":"Fahri","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ibd.20807","article-title":"Mucocutaneous manifestations in inflammatory bowel disease","volume":"15","author":"Y\u00fcksel","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"607","DOI":"10.4103\/0378-6323.45102","article-title":"Cutaneous manifestations in 404 Iranian patients with inflammatory bowel disease: a retrospective study","volume":"74","author":"Moravvej","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R13-10-20210128","first-page":"3","article-title":"Pyoderma gangrenosum: clinical, laboratory and therapeutic approaches. Review of 28 cases [in Portuguese]","volume":"15","author":"Duarte","year":"2009","journal-title":"Dermatol Online J"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/WON.0b013e3181cf7b76","article-title":"Factors affecting ostomy-related complications in Korea","volume":"37","author":"Sung","year":"2010","journal-title":"J Wound Ostomy Continence Nurs"},{"key":"R15-10-20210128","first-page":"28","article-title":"External stoma and peristomal complications following radical cystectomy and ileal conduit diversion: a systematic review","volume":"56","author":"Szymanski","year":"2010","journal-title":"Ostomy Wound Manage"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/DCR.0b013e31819accc6","article-title":"Early diagnosis and early corticosteroid administration improves healing of peristomal pyoderma gangrenosum in inflammatory bowel disease","volume":"52","author":"Funayama","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1346-8138.2009.00756.x","article-title":"Pyoderma gangrenosum on the breast: a case presentation and review of the published work","volume":"37","author":"Mansur","year":"2010","journal-title":"J Dermatol"},{"key":"R18-10-20210128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/SAP.0b013e3181a20b13","article-title":"Pyoderma gangrenosum following free transverse rectus abdominis myocutaneous breast reconstruction: a case report","volume":"64","author":"Schoemann","year":"2010","journal-title":"Ann Plast Surg"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2340\/00015555-0678","article-title":"Progressive refractory ulcer of the nipple: a quiz","volume":"89","author":"Nomura","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1525-1470.2009.01005.x","article-title":"Vulvar pyoderma gangrenosum in a child","volume":"26","author":"Garcovich","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"R23-10-20210128","first-page":"e397","article-title":"Scrotal pyoderma gangrenosum associated with Crohn's disease","volume":"50","author":"Ho","year":"2009","journal-title":"Singapore Med J"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.3346\/jkms.2009.24.6.1200","article-title":"Pyoderma gangranosum of the penis","volume":"24","author":"Kim","year":"2009","journal-title":"J Korean Med Sci"},{"key":"R25-10-20210128","first-page":"85","article-title":"An uncommon localization of pyoderma gangrenosum on the penis of an HIV infected patient in the Ivory Coast [in French]","volume":"102","author":"Ecra","year":"2009","journal-title":"Bull Soc Pathol Exot"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.annder.2010.01.012","article-title":"Recurring pyoderma gangrenosum in pregnancy [in French]","volume":"137","author":"Wierzbicka-Hainaut","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"R27-10-20210128","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.annder.2010.01.007","article-title":"Cutaneous, mucosal and systemic pyoderma gangrenosum [in French]","volume":"137","author":"Poiraud","year":"2010","journal-title":"Ann Dermatol Venereol"},{"key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.amjoto.2008.05.005","article-title":"Pyoderma gangrenosum masquerading as necrotizing fasciitis","volume":"30","author":"Barr","year":"2009","journal-title":"Am J Otolaryngol"},{"key":"R30-10-20210128","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1590\/S0365-05962009000600020","article-title":"Atypical pyoderma gangrenosum following total knee replacement surgery: first report in dermatologic literature","volume":"84","author":"Verma","year":"2009","journal-title":"An Bras Dermatol"},{"key":"R31-10-20210128","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jaad.2009.05.030","article-title":"Pyoderma gangrenosum: a review and update on new therapies","volume":"62","author":"Miller","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"R32-10-20210128","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/archdermatol.2009.57","article-title":"Mycophenolate mofetil as therapy for pyoderma gangrenosum","volume":"145","author":"Eaton","year":"2009","journal-title":"Arch Dermatol"},{"key":"R33-10-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1440-0960.2008.00506.x","article-title":"Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin","volume":"50","author":"De Zwaan","year":"2009","journal-title":"Australas J Dermatol"},{"key":"R34-10-20210128","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/09546630902936778","article-title":"Nonpsoriatic dermatologic uses of monoclonal antibody therapy","volume":"20","author":"Sockolov","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"R35-10-20210128","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1136\/gut.2005.074815","article-title":"Infliximab for the treatment of pyoderma gangrenosum: a randomized, double blind, placebo controlled trial","volume":"33","author":"Brooklyn","year":"2006","journal-title":"Gut"},{"key":"R36-10-20210128","first-page":"e8","article-title":"Adalimumab therapy for recalcitrant pyoderma gangrenosum","volume":"5","author":"Fonder","year":"2006","journal-title":"J Burns Wounds"},{"issue":"Suppl 2","key":"R37-10-20210128","doi-asserted-by":"crossref","first-page":"S128","DOI":"10.1016\/j.jaad.2005.10.058","article-title":"The treatment of pyoderma gangraenosum using etanercept","volume":"54","author":"Roy","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"R38-10-20210128","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1365-2230.2005.01972.x","article-title":"Pyoderma gangrenosum treated with anti-TNF alpha therapy (etanercept)","volume":"31","author":"Pastor","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"R39-10-20210128","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1534734607300912","article-title":"Improvement of idiopathic pyoderma gangrenosum during treatment with antitumor necrosis factor alpha monoclonal antibody","volume":"6","author":"Dini","year":"2007","journal-title":"Int J Low Extrem Wounds"},{"key":"R40-10-20210128","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1365-4632.2007.03286.x","article-title":"Etanercept for the treatment of refractory pyoderma gangrenosum: a brief series","volume":"46","author":"Charles","year":"2007","journal-title":"Int J Dermatol"},{"key":"R41-10-20210128","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1111\/j.1365-2133.2007.08212.x","article-title":"Adalimumab for treatment of pyoderma gangrenosum","volume":"157","author":"Pomerantz","year":"2007","journal-title":"Br J Dermatol"},{"key":"R42-10-20210128","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archderm.143.3.306","article-title":"Adalimumab treatment for pyoderma gangrenosum","volume":"143","author":"Heffernan","year":"2007","journal-title":"Arch Dermatol"},{"key":"R43-10-20210128","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000096917","article-title":"Pyoderma vegetans associated with severe psoriatic arthritis: good response to etanercept","volume":"214","author":"Carrera","year":"2007","journal-title":"Dermatology"},{"key":"R44-10-20210128","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jamcollsurg.2007.07.023","article-title":"Management of peristomal pyoderma gangrenosum","volume":"206","author":"Poritz","year":"2008","journal-title":"J Am Coll Surg"},{"key":"R45-10-20210128","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-4632.2008.03412.x","article-title":"Pyoderma gangrenosum: rebel without a cure?","volume":"47","author":"Jacob","year":"2008","journal-title":"Int J Dermatol"},{"key":"R46-10-20210128","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2230.2007.02607.x","article-title":"Widespread idiopathic pyoderma gangrenosum evolved from ulcerative to vegetative type: a 10-year history with a recent response to infliximab","volume":"33","author":"Marzano","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"R47-10-20210128","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bjps.2006.11.011","article-title":"Treatment of pyoderma gangrenosum with the anti-TNFalpha drug: Etanercept","volume":"61","author":"Rogge","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R48-10-20210128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000111515","article-title":"Treatment of idiopathic pyoderma gangrenosum with infliximab: induction dosing regimen or on-demand therapy?","volume":"216","author":"Adi\u015fen","year":"2008","journal-title":"Dermatology"},{"key":"R49-10-20210128","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2177\/jsci.31.454","article-title":"Infliximab for a girl with refractory pyoderma gangrenosum [in Japanese]","volume":"31","author":"Nozawa","year":"2008","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"R50-10-20210128","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0001-7310(08)76179-9","article-title":"Two cases of eruptive pyoderma gangrenosum associated with cocaine use [in Spanish]","volume":"99","author":"Roche","year":"2008","journal-title":"Actas Dermosifiliogr"},{"key":"R51-10-20210128","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1111\/j.1572-0241.2008.02094_14.x","article-title":"Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis","volume":"103","author":"Fern\u00e1ndez","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"R52-10-20210128","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/ibd.20481","article-title":"Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis","volume":"14","author":"Ermis","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R54-10-20210128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1525-1470.2008.00825.x","article-title":"Idiopathic infantile pyoderma gangrenosum with stridor responsive to infliximab","volume":"26","author":"Rajan","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"R55-10-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2340\/00015555-0540","article-title":"Septic shock after treatment of pyoderma gangrenosum with infliximab","volume":"89","author":"W\u00f6lbing","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"R56-10-20210128","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1111\/j.1365-2230.2008.03018.x","article-title":"Superficial granulomatous pyoderma treated preoperatively with infliximab","volume":"34","author":"Akhras","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"R57-10-20210128","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.3748\/wjg.15.2293","article-title":"Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: two birds with one stone","volume":"15","author":"Zold","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R58-10-20210128","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/ibd.20748","article-title":"Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease","volume":"15","author":"Alkhouri","year":"2009","journal-title":"Inflamm Bowel Dis"},{"key":"R59-10-20210128","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1468-3083.2008.02680.x","article-title":"An open-label pilot study of alefacept for the treatment of pyoderma gangrenosum","volume":"22","author":"Foss","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R60-10-20210128","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1556\/oh.2010.28786","article-title":"Pyoderma gangrenosum treated successfully with visilizumab in patients with ulcerative colitis [in Hungarian]","volume":"151","author":"Lorincz","year":"2010","journal-title":"Orv Hetil"},{"key":"R61-10-20210128","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/j.1365-2133.2009.09404.x","article-title":"Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra","volume":"161","author":"Brenner","year":"2009","journal-title":"Br J Dermatol"},{"key":"R63-10-20210128","first-page":"181","article-title":"FK-506 ointment: an effective adjuvant therapy to treat a dramatic case of pyoderma gangrenosum of unilateral hand","volume":"12","author":"Lucchina","year":"2009","journal-title":"Chin J Traumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/BOR.0b013e328341152f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:42:29Z","timestamp":1786041749000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002281-201101000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e328341152f","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}